Glenmark Pharmaceuticals

Glenmark is a leading, research-led global pharmaceutical company with a diverse business that includes branded products, affordable generics, and over-the-counter (OTC) medicines. The company's vision is to emerge as a top global pharmaceutical player by leading with research and discovering new, impactful medicines for patients worldwide. A core principle guiding the company is its goal to democratize healthcare, making it available to more people through continuous innovation in its products and therapies. It specializes in creating medicines for key health areas such as Respiratory diseases, skin conditions (Dermatology), and cancer treatment (Oncology), addressing significant patient needs. Glenmark's strategy is centered on advancing its value chain, expanding its global footprint, and creating shareholder value through operational excellence and innovation. Currently, its branded medicines make up about 60% of total revenue, highlighting a strategic focus that the company aims to expand in the future.;